Uterine Hemorrhage: Clinical Trials

58 trials for Uterine Hemorrhage, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

58 completed. 58 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 458Completed 58

Follow Uterine Hemorrhage: new trials by email Literature Review of Uterine Hemorrhage trials Research Report on Uterine Hemorrhage

Trials (filtered) newest first · largest first

All 58 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing Intra-Umbilical Versus Intravenous Oxytocin in Women During the Third Stage of Labor for Reducing Blood Loss
Oxytocin after delivery, Intraumbilical oxytocin - Postpartum Bleeding, Oxytocin
Phase 4CompletedCMH Multan Institute of Medical Sciences602025-08-132026-05-05
Myo-Inositol and D-Chiro-Inositol for Menstrual Irregularities and Hormone Changes in Women With Polycystic Ovarian Syndrome
Myo-Inositol and D-Chiro-Inositol Combination Therapy, placebo (folic acid) - Polycystic Ovary Syndrome (PCOS), Myo-inositol
Phase 4CompletedNishtar Medical University602025-06-012026-07-14
Rate of Tranexamic Acid Administration on Blood Pressure (RateTXA) Study.
Tranexamic Acid (TXA) - Healthy Participants
Phase 4CompletedUniversity of British Columbia1102024-03-302026-10-08
Comparison of the Efficacy of Misoprostol and Tranexamic Acid for Postpartum Hemorrhage Prophylaxis in Cesarean Delivery
Tranexamic acid, Misoprostol 200mcg Tab - Postpartum Hemorrhage, Cesarean Section Complications
Phase 4CompletedAnkara Etlik City Hospital1922023-12-012026-08-06
Prophylactic Methylergonovine for Twin Cesarean
Methylergonovine, Placebo - Twin; Complicating Pregnancy, Postpartum Hemorrhage
Phase 4CompletedColumbia University662023-03-072025-06-13
Use of Chitosan Powder in Loop Electrosurgical Excision Procedure
Chitosan - Vaginal Bleeding, Loop Electrosurgical Excision
Phase 4CompletedErzincan Military Hospital1302022-12-152024-06-26
Use of Tranexamic Acid After Vaginal Delivery with Episiotomy a RCT Placebo Control Trail
Tranexamic acid, Placebo - Episiotomy Wound, Anemia
Phase 4CompletedAssuta Ashdod Hospital1502022-07-252024-12-05
IV Ketorolac on Platelet Function Post-Cesarean Delivery
Ketorolac Tromethamine 30 MG/ML, Placebos - Analgesia, Obstetrical, Coagulation Defect; Postpartum
Phase 4CompletedBeth Israel Deaconess Medical Center402021-01-182026-05-29
Alternate Day Versus Daily Oral Iron Therapy in Adolescents
Ferrous sulfate - Iron Deficiency Anemia, Heavy Menstrual Bleeding
Phase 4CompletedBaylor College of Medicine132020-12-212023-09-13
Treatment of Prolonged Uterine Bleeding of Etonogestrel (ENG)-Releasing Implant
Norethisterone 10mg/day, Placebo - Breakthrough Bleeding
Phase 4CompletedUniversity of Sao Paulo1142020-09-152024-09-23
Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users
Placebo, Curcumin - Bleeding, Implants
Phase 4CompletedOregon Health and Science University582020-04-152024-07-03
A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
Elagolix, Placebo - Uterine Fibroids
Phase 4CompletedAbbVie822019-04-122022-03-31
UA Versus UAE in Treatment of Fibroids
Ulipristal Oral Tablet, Uterine artery embolization - Uterine Fibroid
Phase 4CompletedAin Shams Maternity Hospital702019-03-132021-04-06
Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial
15-methyl prostaglandin F2α, Methylergonovine Maleate - Postpartum Hemorrhage, Uterine Atony
Phase 4CompletedBrigham and Women's Hospital1002019-03-012025-10-16
Buccal Misoprostol Versus IV Oxytocin in Prevention of Postpartum Hemorrhage
Misoprostol, Oxytocin - Postpartum Hemorrhage
Phase 4CompletedAssiut University1542018-11-012021-09-29
Tranexamic Acid for the Control of Blood Loss at Elective Cesarean Section
normal saline, 1gm tranexamic acid, 0.5 gm tranexamic acid - Cesarean Section Complications
Phase 4CompletedAswan University Hospital3602018-11-012020-08-05
Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean
carbetocin, Syntometrine - Post Partum Hemorrhage
Phase 4CompletedCairo University12002018-10-012020-01-03
The Effect of Preoperative and Post Operative Misoprostol Administration on Intraoperative Blood Loss and Postpartum Hemorrhage in CS
cesarean section, Misoprostol, Oxytocin - Post Partum Hemorrhage
Phase 4CompletedCairo University2002018-09-022023-06-27
Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections
Oxytocin, Carbetocin - Postpartum Hemorrhage
Phase 4CompletedUniversity of Zurich5502018-08-072023-05-24
CARBETOCIN VERSUS RECTAL MISOPROSTOL FOR MANAGEMENT OF THIRD STAGE OF LABOR IN WOMEN AT LOW RISK OF POSTPARTUM HEMORRHAGE
Carbetocin, Misoprostol - Postpartum Hemorrhage
Phase 4CompletedCairo University1502018-07-022019-10-11

Showing 20 of 58. Sign in to see all of them.

Narrower conditions

Postpartum Hemorrhage (35)  ·  Menorrhagia (15)  ·  Metrorrhagia (10)  ·  Hemorrhage (6)  ·  Leiomyoma (5)  ·  Uterine Inertia (5)  ·  Anemia (3)  ·  Pain (3)  ·  Agnosia (2)  ·  Blood Loss, Surgical (2)  ·  Hemostatic Disorders (2)  ·  Menstruation Disturbances (2)  ·  Pain, Postoperative (2)  ·  Postoperative Hemorrhage (2)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (58)  ·  Pathologic Processes (58)  ·  Pathological Conditions, Signs and Symptoms (58)  ·  Urogenital Diseases (58)  ·  Hemorrhage (52)  ·  Obstetric Labor Complications (35)  ·  Puerperal Disorders (35)  ·  Pregnancy Complications (34)  ·  Female Urogenital Diseases (23)  ·  Genital Diseases (23)  ·  Genital Diseases, Female (23)  ·  Uterine Diseases (23)  ·  Menstruation Disturbances (13)  ·  Hematologic Diseases (6)

Interventions

Tranexamic Acid (13)  ·  Misoprostol (10)  ·  Oxytocin (9)  ·  carbetocin (9)  ·  Levonorgestrel (3)  ·  Saline Solution (3)  ·  Sodium Chloride (3)  ·  Folic Acid (2)  ·  Ketorolac (2)  ·  Ketorolac Tromethamine (2)  ·  Methylergonovine (2)  ·  Naproxen (2)  ·  Tamoxifen (2)  ·  Uterine Artery Embolization (2)  ·  syntometrine (2)

Sponsors

Cairo University (4)  ·  Assiut University (3)  ·  Gynuity Health Projects (3)  ·  Oregon Health and Science University (3)  ·  Bayer (2)  ·  Talkha Central Hospital (2)  ·  AbbVie (1)  ·  Abimbola Famuyide (1)  ·  Ain Shams Maternity Hospital (1)  ·  Al-Kindy College of Medicine (1)  ·  Ankara Etlik City Hospital (1)  ·  Aristotle University Of Thessaloniki (1)  ·  Assuta Ashdod Hospital (1)  ·  Aswan University Hospital (1)  ·  Baylor College of Medicine (1)

Countries

United States (20)  ·  Egypt (14)  ·  France (3)  ·  Canada (2)  ·  Ireland (2)  ·  Pakistan (2)  ·  Switzerland (2)  ·  Turkey (Türkiye) (2)  ·  Argentina (1)  ·  Austria (1)  ·  Brazil (1)  ·  Denmark (1)  ·  Finland (1)  ·  Greece (1)  ·  Iraq (1)

Top investigators

Beverly Winikoff, MD, MPH (2)  ·  Abimbola O. Famuyide, MBBS (1)  ·  Ahmed Maged (1)  ·  Ahmed Maged, MD (1)  ·  Ahmed S Alnuaimi, PhD (1)  ·  Alaa A Hussein, FICOG, MD (1)  ·  Alan T Tita, MD, PhD (1)  ·  Amro M Hetta, M.B., Ch.B. (1)  ·  Amro M. Hetta, MS Student (1)  ·  Anita L. Nelson, M.D. (1)

Results publications

PMID 19955104, PMID 20378611, PMID 20472114, PMID 21162725, PMID 22227638, PMID 23635728, PMID 24405687, PMID 24682613, PMID 24788209, PMID 25594352, PMID 25600160, PMID 26534874, PMID 29141040, PMID 31226322, PMID 31304593, PMID 31736069, PMID 32143721, PMID 32448257, PMID 32649493, PMID 33169839, PMID 33232518, PMID 33713384, PMID 34932836, PMID 37116825, PMID 37769311, PMID 39326051, PMID 41114449

NIH funding

2005 (1), K12HD001258 (1), R21HD091337 (1)